Estradiol and progesterone regulate the proliferation of human breast epithelial cells

Fertility and Sterility

Volumn 69, Issue 5, 1998, Pages 963-969

  Foidart, Jean Michel ^a,b   Colin, Claude ^b   Denoo, Xavier ^c   Desreux, Joëlle ^b   Béliard, Aude ^c   Fournier, Sabine ^c   De Lignières, Bruno ^c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Centre Hospitalier Regional de La Citadelle   (Belgium)

^c NONE

Author keywords

DNA ploidy; Estradiol percutaneous administration; Human; In vivo; Mitotic index; Normal breast; Progesterone; Proliferating cell nuclear antigen; Proliferation markers; Steroid concentration

Indexed keywords

ESTRADIOL; PROGESTERONE;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CELL PROLIFERATION; ESTRADIOL BLOOD LEVEL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BREAST; CELL DIVISION; DOUBLE-BLIND METHOD; EPITHELIAL CELLS; ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; PROGESTERONE;

EID: 0032079862     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00042-9     Document Type: Article

References (29)

1. 1. Key DL, Pike M. The role of estrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24:29-43.
2. 2. Going J, Anderson T, Battersby S. Proliferative and secretory activity in human breast during natural and artificial menstrual cycle. Am J Pathol 1988;130:193-203.
3. 3. Vorherr H. Fibrocystic breast disease: pathophysiology, pathomorphometry, clinical picture, and management. Am J Obstet Gynecol 1986;154:161-79.
4. 4. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332: 1589-93.
5. 5. Gambrell RD Jr. Use of progestogen therapy. Am J Obstet Gynecol 1987;156:1304-13.
6. 6. Risch HA, Howe GR. Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage-cohort-study.
7. 7. Stanford J, Weiss WS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995; 274:137-42.
8. 8. Anderson TJ, Battersby S, King RJB, McPherson K, Going JJ. Oral contraceptive use influences resting breast proliferation. Hum Pathol 1989;20:1139-44.
9. 9. Meyer JS. Cell proliferation in normal human breast ducts, fibroadenomas and other duct hyperplasias, measured by nuclear labelling with tritiated thymidine: effects of menstrual phase, age, and oral contraceptive hormones. Hum Pathol 1977;8:67-81.
10. 10. Longacre TA, Bartow SA. A correlation morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 1986;10:382-93.
11. 11. Potten CS, Watson RJ, Williams GT, Tickle S, Roberts SA, Harris M, et al. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 1988;58:163-70.
12. 12. McManus MJ, Welsch CW. The effect of estrogen, progesterone, thyroxine and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice. Cancer 1984;54:1920-7.
13. 13. Mauvais-Jarvis P, Kuttenn F, Gompel A. Anti-estrogen action of progesterone in breast cancer. Breast Cancer Res Treat 1986;8:179-88.
14. 14. Laidlaw IJ, Clarke RB, Howell A, Owen AW, Potten CS, Anderson E. The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 1995;136:164-71.
15. 15. Chang KJ, Lee TTY, Linares-Cruz G, Fournier S, de Lignières B. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil Steril 1995;63:785-91.
16. 16. Simon JA. Micronized progesterone: vaginal and oral uses. Clin Obstet Gynecol 1995;38:902-14.
17. 17. De Boever J, Verheugen C, Van Maele G, Vandekerkhove D. Steroid concentrations in serum, glandular breast tissue and breast cyst fluid of control and progesterone-treated patients. In: Angeli A, editor. Endocrinology of cystic breast disease. New York: Raven Press, 1983:93-9.
18. 18. Barrat J, de Lignières B, Marpeau L, Larue L, Fournier S, Nahoul K, et al. Effect in vivo de l'administration locale de progestérone sur l'activité mitotique des galactophores humains. J Gynecol Obstet Biol Reprod 1990;19:269-74.
19. 19. Waseem NH, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen/PCNA: structural conservation and the detection of a nucleolar form. J Cell Sci 1990;96:121-9.
20. 20. Dietrich DR. Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit Rev Toxicol 1993;23:77-109.
21. 21. Bravo R, Frank R, Bundell PA, MacDonald-Bravo H. Cyclin/PCNA is the auxillary protein of DNA polymerase-d. Nature 1987;326: 515-7.
22. 22. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
23. 23. Botella J, Duc I, Delansorne R, Paris J, Lahlou B. Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative. J Pharmacol Exp Ther 1989;248:758-61.
24. 24. Jeng MH, Parker CJ, Jordan VC. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. Cancer Res 1992;52:6539-46.
25. 25. Markiewicz L, Hochberg RB, Gurpide E. Intrinsic estrogenicity of some progestogenic drugs. J Steroid Biochem Mol Biol 1992;51:53-8.
26. 26. Botella J, Duranti E, Viader V, Duc I, Delansorne R, Paris J. Lack of estrogenic potential of progesterone or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells. J Steroid Biochem Mol Biol 1991;50: 41-7.
27. 27. Cappelletti V, Miodini P, Fioravanti L, Di Fronzo G. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines. Anticancer Res 1995;15:2551-5.
28. 28. Thijssen JH, van der Burg B. Growth inhibition by anti-estrogens and progestins in TGF-beta-resistant and -sensitive breast-tumor cells. Int J Cancer 1996;65:682-7.
29. 29. Hofland LJ, van der Burg B, van Eijck CH, Sprij DM, van Koetsveld PM, Lamberts SW. Role of tumor-derived fibroblasts in the growth of primary cultures of human breast cancer cells: effects of epidermal growth factor and the somatostatin analogue octreotide. Int J Cancer 1995;60:93-9.